divider

Pipeline, Portfolio, and Products

Driven by a patient-first mindset, we connect technology and life-sciences expertise to propel patient-needed therapies sooner.

Pipeline **

Sumitovant Development Pipeline
Pre-Clinical Phase 1 Phase 2 Phase 3 Approved Therapy Indication
VIBEGRON Urology Overactive Bladder
VIBEGRON Urology Overactive Bladder (men with BPH)
URO-902 Urology Overactive Bladder
RVT-802 Rare Disease Pediatric Congenital Athymia
RELUGOLIX *+ Oncology Prostate Cancer
RELUGOLIX *+ Women’s Health Uterine Fibroids
RELUGOLIX *+ Women’s Health Endometriosis
RELUGOLIX * Women’s Health Contraception
MVT-602 * Women’s Health Female Infertility
SP-101 Respiratory Cystic Fibrosis
RODATRISTAT ETHYL Respiratory Pulmonary Arterial Hypertension
ALTA-2530 Respiratory Transplant–Associated
Bronchiolitis Obliterans Syndrome
KSP - 1007 Infectious Disease Complicated Infections

** This list is comprised only of therapies/indications in the U.S. and does not reflect approvals outside the U.S.

* Products of Myovant, a publicly listed company, in which Sumitovant holds a majority ownership interest.

+ Licensed to third parties for development/commercialization in certain territories; for more details, visit the product websites provided below.

divider

Portfolio Companies


Urovant

Creating innovative treatment options for people living with urologic conditions.

Enzyvant

Advancing novel regenerative therapies for pediatric rare diseases.

Myovant *

Women’s health and prostate cancer.

Spirovant

Developing gene therapies for genetic lung diseases.

Altavant

Developing therapies addressing rare respiratory diseases.

* Sumitovant holds a majority ownership interest in Myovant, a publicly listed company.

divider

Products


gemtesa

To learn more about Gemtesa, visit the following website:
www.gemtesa.com

Please use the link below to download a PDF version of the following documents: Full Prescribing Information  |  Patient Medication Guide

rethymic

To learn more about Rethymic, visit the following website:
www.rethymic.com

Please use the link below to download a PDF version of the following documents: Full Prescribing Information

orgovyx

To learn more about Orgovyx, visit the following website:
www.myovant.com

Please use the link below to download a PDF version of the following documents: Full Prescribing Information  |  Patient Medication Guide

myfembree

To learn more about Myfembree, visit the following website:
www.myovant.com

Please use the link below to download a PDF version of the following documents: Full Prescribing Information  |  Patient Medication Guide